Back to Treatments

Treatment

Trastuzumab (HER2-targeted therapy)

1
Conditions
89
Trials
75K
Participants
55%
Average Safety

Condition Evidence

Breast cancer

89 trials · 75K participants

85% effectiveness · 55% safety
Trastuzumab (HER2-targeted therapy) | DFDA